To me, it looks like Daryl DeKarske has replaced James Shaw.
Also, note the emphasis on the word “global”. I hope this means that with NNZ-2591, ex-US market entry is considered much earlier than with trofinetide.
Daryl has extensive experience leading global regulatory strategy and execution….
He has ideal experience and his broad expertise will make a big difference as we advance NNZ-2591 in multiple indications for global markets….
Ann: Neuren appoints Daryl DeKarske to executive team, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.81 |
Change
0.330(2.00%) |
Mkt cap ! $2.109B | |||
| Open | High | Low | Value | Volume |
| $16.65 | $16.90 | $16.33 | $3.903M | 232.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 194 | $16.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.81 | 1173 | 4 |
View Market Depth
| Last trade - 14.41pm 29/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |